GKOS vs. VEEV: Glaukos vs. Veeva Systems Stock Comparison
How do Glaukos (GKOS) and Veeva Systems (VEEV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Glaukos (GKOS) and Veeva Systems (VEEV) both fall under the Health Care Equipment & Services industry group, but GKOS is classified in Health Care Equipment & Supplies while VEEV is classified in Health Care Technology.
| Profile Item | GKOS | VEEV |
|---|---|---|
| Name | Glaukos Corp. | Veeva Systems Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Technology |
| GICS Sub-Industry | Health Care Equipment | Health Care Technology |
| Market Capitalization | 13.28 billion USD | 49.18 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | June 25, 2015 | October 16, 2013 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | GKOS | VEEV |
|---|---|---|
| Total Return (1Y) | 179.91% | 3.92% |
| Total Return (3Y, Annualized) | 55.51% | 22.52% |
| Total Return (5Y, Annualized) | 35.14% | -0.87% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | GKOS | VEEV |
|---|---|---|
| Volatility (1Y, Annualized) | 61.24% | 43.36% |
| Beta (5Y) | 0.68 | 0.88 |
| Max Drawdown (5Y) | -53.68% | -52.79% |
| Avg. Volume (3M) | 1.15M | 1.64M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | GKOS | VEEV |
|---|---|---|
| Sharpe Ratio (1Y) | 2.87 | -0.01 |
| Sortino Ratio (1Y) | 5.93 | -0.01 |
Profitability
ROE (TTM)
Glaukos (GKOS) reports a negative ROE of -22.84%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Veeva Systems (VEEV) reports 14.43%, ranking against industry peers normally.
GKOS
Health Care Equipment & Services industry group
-22.84%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- GKOS
- -22.84%
- Min
- -47.01%
VEEV
Health Care Equipment & Services industry group
14.43%
- Max
- 47.61%
- VEEV
- 14.43%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Glaukos (GKOS) reports a negative net margin of -24.60%, usually indicating a net loss over the period. Meanwhile Veeva Systems (VEEV) reports 29.35%, ranking against industry peers normally.
GKOS
Health Care Equipment & Services industry group
-24.60%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- GKOS
- -24.60%
- Min
- -28.46%
VEEV
Health Care Equipment & Services industry group
29.35%
- VEEV
- 29.35%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Veeva Systems (VEEV) at 29.64% operates in the top operating margin quartile, ahead of Glaukos (GKOS) at 0.39%, which runs around its industry’s norm.
GKOS
Health Care Equipment & Services industry group
0.39%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- GKOS
- 0.39%
- Q1
- -0.28%
- Min
- -16.29%
VEEV
Health Care Equipment & Services industry group
29.64%
- Max
- 35.43%
- VEEV
- 29.64%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | GKOS | VEEV |
|---|---|---|
| ROE (TTM) | -22.84% | 14.43% |
| ROA (TTM) | -3.90% | 7.58% |
| Net Margin (TTM) | -24.60% | 29.35% |
| Operating Margin (TTM) | 0.39% | 29.64% |
| Gross Margin (TTM) | 81.13% | 74.96% |
Growth
Revenue Growth
Glaukos (GKOS) at 32.33% sits in the top revenue growth quartile, while Veeva Systems (VEEV) at 16.34% is closer to the peer norm — faster top-line expansion for GKOS.
EPS Growth
Only one side can be read here: Veeva Systems (VEEV) reports EPS growth of 25.93%, ranked against its industry; Glaukos (GKOS) has no EPS growth figure this period.
Growth Metrics
| Metric | GKOS | VEEV |
|---|---|---|
| Revenue Growth (YoY) | 32.33% | 16.34% |
| Revenue Growth (3Y CAGR) | 21.51% | 14.03% |
| EPS Growth (YoY) | -- | 25.93% |
| EPS Growth (3Y CAGR) | -- | 21.94% |
Financial Strength
Current Ratio (MRQ)
Both Glaukos (GKOS) at 4.57 and Veeva Systems (VEEV) at 5.46 post current ratio above their industries’ typical mid-ranges — short-term liquidity appears comfortable, though unusually high readings can point to idle current assets.
GKOS
Health Care Equipment & Services industry group
4.57
- Max
- 7.59
- GKOS
- 4.57
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
VEEV
Health Care Equipment & Services industry group
5.46
- Max
- 7.59
- VEEV
- 5.46
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Glaukos (GKOS) at 0.15 and Veeva Systems (VEEV) at 0.02 keep leverage in the lower quartile of their industries, with less balance-sheet debt relative to equity than most peers.
GKOS
Health Care Equipment & Services industry group
0.15
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- GKOS
- 0.15
- Min
- 0.00
VEEV
Health Care Equipment & Services industry group
0.02
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- VEEV
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | GKOS | VEEV |
|---|---|---|
| Current Ratio (MRQ) | 4.57 | 5.46 |
| Debt / Equity (MRQ) | 0.15 | 0.02 |
| Net Debt / EBITDA | -- | -6.59 |
Dividends
Dividend Yield (TTM)
Neither Glaukos (GKOS) nor Veeva Systems (VEEV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
VEEV
Health Care Equipment & Services industry group
0.00%
- VEEV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Glaukos (GKOS) nor Veeva Systems (VEEV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
VEEV
Health Care Equipment & Services industry group
0.00%
- VEEV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | GKOS | VEEV |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Veeva Systems (VEEV) trades at 49.79 times trailing earnings, ranked against its peers, while Glaukos (GKOS) has no P/E ratio this period.
GKOS
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GKOS
- --
VEEV
Health Care Equipment & Services industry group
49.79
- Max
- 80.41
- VEEV
- 49.79
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Investors are paying well above the peer range per dollar of sales for both Glaukos (GKOS) at 19.24 and Veeva Systems (VEEV) at 14.22 — each P/S ratio clears its industry’s benchmark range.
GKOS
Health Care Equipment & Services industry group
19.24
- GKOS
- 19.24
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
VEEV
Health Care Equipment & Services industry group
14.22
- VEEV
- 14.22
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Both look rich against book: Veeva Systems (VEEV) at 6.61 sits in the upper P/B ratio quartile, and Glaukos (GKOS) at 18.51 prices even higher, above its industry range.
GKOS
Health Care Equipment & Services industry group
18.51
- GKOS
- 18.51
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
VEEV
Health Care Equipment & Services industry group
6.61
- Max
- 11.68
- VEEV
- 6.61
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | GKOS | VEEV |
|---|---|---|
| P/E Ratio (TTM) | -- | 49.79 |
| P/S Ratio (TTM) | 19.24 | 14.22 |
| P/B Ratio (MRQ) | 18.51 | 6.61 |
| Free Cash Flow Yield (TTM) | 0.40% | 2.56% |